Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 847, Issue 2, 2007, Pages 174-181

  Li, Shuijun ^a   Liu, Gangyi ^a   Jia, Jingying ^a   Liu, Yun ^a   Pan, Cheng ^a   Yu, Chen ^a   Cai, Yongbao ^a   Ren, Jianying ^a  

^a SHANGHAI XUHUI CENTRAL HOSPITAL   (China)

Author keywords

Antiarrhythic drugs; LC MS MS; Therapeutic drug monitoring

Indexed keywords

ACETONITRILE; LIQUID CHROMATOGRAPHY; LIVING SYSTEMS STUDIES; MASS SPECTROMETRY; METABOLITES; PROTEINS;

ANTIARRHYTHIC DRUGS; DEPROTEINIZATION; ELECTROSPRAY IONIZATION (ESI); HUMAN PLASMAS; MULTIPLE REACTION MONITORING (MRM); THERAPEUTIC DRUG MONITORING (TDM);

DRUG PRODUCTS;

ACETONITRILE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BISOPROLOL; CARVEDILOL; DILTIAZEM; DRUG METABOLITE; FORMIC ACID; METOPROLOL; MEXILETINE; NORVERAPAMIL; PROPRANOLOL DERIVATIVE; SOTALOL; VERAPAMIL; WATER;

ACCURACY; ARTICLE; CALIBRATION; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; ELECTROSPRAY; FLOW RATE; HUMAN; LIQUID CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATENOLOL; BISOPROLOL; CARBAZOLES; CHROMATOGRAPHY, LIQUID; DILTIAZEM; HUMANS; METOPROLOL; MEXILETINE; MOLECULAR STRUCTURE; PROPANOLAMINES; PROPRANOLOL; REPRODUCIBILITY OF RESULTS; SOTALOL; TANDEM MASS SPECTROMETRY; VERAPAMIL;

EID: 33847331063     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.10.013     Document Type: Article

References (27)

1. Hancox J.C., Patel K.C., and Jones J.V. Heart 84 (2000) 14
2. Kannankeril P.J., and Fish F.A. Progr. Pediatric Cardiol. 17 (2003) 41
3. X.Y. Zhu, The AADs in Pharmacology, third ed., 1993, p. 207.
4. A. Capucci, D. Aschieri, Eur. Heart J. Suppl. 5 (Suppl. H) (2003) H8.
5. V. Williams, in: E. Sandoe, E. Flenstead-Jensen, E.H. Olesen (Eds.), Proceedings of the Symposium on Cardiac Arrhythmias, 1970, p. 449.
6. Williams V. Handbook Exp. Pharm. 89 (1989) 45
7. Singh B.N. Am. J. Cardiol. 80 (1997) 4
8. State Food and Drug Administration of China, National essential drugs List, 2004.
9. Valdes R.J., Jortani S.A., and Gheorghiade M. Clin. Chem. 44 (1998) 1096
10. Takada M., Goto T., Saito M., et al. J. Clin. Pharm. Ther. 30 (2005) 5
11. Quaglia M.G., Donati E., Fanali S., et al. J. Pharm. Biomed. Anal. 37 (2005) 695
12. Kollroser M., and Schober C. J. Chromatogr. B 766 (2002) 219
13. Fang J., Semple H.A., and Song J. J. Chromatogr. B 809 (2004) 9
14. Modamio P., Lastra C.F., Montejo O., and Marino E.L. Int. J. Pharm. 130 (1996) 137
15. Badaloni E., D'Acquarica I., Gasparrini F., et al. J. Chromatogr. B 796 (2003) 45
16. Molden E., Helen B.G., Christensen H., and Reubsaet L. J. Pharm. Biomed. Anal. 33 (2003) 275
17. Walles M., Thum T., Levsen K., and Borlak J. J. Chromatogr. B 798 (2003) 265
18. Mullett W.M., Walles M., Levsen K., et al. J. Chromatogr. B 801 (2004) 297
19. Johnson R.D., and Lewis R.J. Forensic Sci. Int. 156 (2006) 106
20. Stagni G., and Gillespie W.R. J. Chromatogr. B 667 (1995) 349
21. Delamoye M., Duverneuil C., Paraire F., Mazancourt P.D., and Alvarez J.C. Forensic Sci. Int. 141 (2004) 23
22. Borges N.C., Mendes G.D., Barrientos-Astigarraga R.E., et al. J. Chromatogr. B 827 (2005) 165
23. Ney C.B., Gustavo D.M., Diogo O.S., et al. J. Chromatogr. B 822 (2005) 253
24. Lanchote V.L., Bonato P.S., Dreossi S.A., et al. J. Chromatogr. B 685 (1996) 281
25. Lim C.K., and Lord G. Biol. Pharm. Bull. 25 (2002) 547
26. FDA, Guidance for industry, bioanalytical method validation, May 2001, http://www.fda.gov/cder/guidance/4252fnl.pdf.
27. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019